Challenging problems in advanced malignancy: Case 2. Disseminated intravascular coagulation in metastatic hormone-refractory prostate cancer

Journal of Clinical Oncology

Volumn 21, Issue 16, 2003, Pages 3170-3171

  Kampel, Lewis J ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRAMUSTINE PHOSPHATE; HEPARIN; PACLITAXEL; ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;

AGED; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONTINUOUS INFUSION; CRYOPRECIPITATE; DISSEMINATED INTRAVASCULAR CLOTTING; HUMAN; LABORATORY TEST; LOW DRUG DOSE; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROSTATE CANCER; THROMBOCYTE TRANSFUSION; ADENOCARCINOMA; BONE TUMOR; FATALITY; METASTASIS; PATHOLOGY; PROSTATE TUMOR;

ADENOCARCINOMA; AGED; ANGIOGENESIS INHIBITORS; ANTINEOPLASTIC AGENTS, HORMONAL; BONE NEOPLASMS; DISSEMINATED INTRAVASCULAR COAGULATION; FATAL OUTCOME; HUMANS; MALE; PACLITAXEL; PROSTATIC NEOPLASMS;

EID: 0041912689     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2003.08.102     Document Type: Article

References (15)

1. Green KB, Silverstein RL: Hypercoagulability in cancer. Hematol Oncol Clin North Am 10:499-530, 1996
2. Sallah S, Wan JY, Nguyen NP, et al: Disseminated intravascular coagulation in solid tumors: Clinical and pathologic study. Thromb Haemost 86:828-833, 2001
3. Jurgens R, Trautwein H: Ûber fibrinopenie (fibrinogenopenie) beim erwaschsener nebst bermerkungen über die herkwas des fibrinogens. Deutsch Arch Klin Med 169:28-43, 1930
4. Marder M, Weiner M, Shulman P, et al: A fibrinogenemia occurring in a case of malignancy of the prostate with bone metastases. NY State J Med 49:1197-1198, 1949
5. Tagnon HJ, Whitmore WF, Schulman P: Fibrinolysis in metastatic cancer of the prostate. Cancer 5:9-12, 1952
6. Rodriguez-Erdmann F: Bleeding due to increased intravascular blood coagulation, hemorrhagic syndrome caused by consumption of blood clotting factors (consumption-coagulopathies). N Engl J Med 273:1370-1378, 1965
7. Spector JI, Zimbler H: Cancer of the prostate presenting as disseminated intravascular coagulation. Can Med Assoc J 136:570-573, 1987
8. Doll DC, Kerr DM, Greenberg DR: Acute gastrointestinal bleeding as the presenting manifestation of prostate cancer. Cancer 58:1374-1377, 1986
9. Litt MR, Bell WR, Lepor HA: Disseminated intravascular coagulation in prostatic carcinoma reversed by ketoconazole. JAMA 258:1361-1362, 1987
10. Harvey MH, Osborn DE, Hutchinson RM: Disseminated intravascular coagulation following transrectal prostatic biopsy. Br J Urol 59:363-364, 1987
11. Cooper DL, Sandler AB, Wilson LD, et al: Disseminated intravascular coagulation and excessive fibrinolysis in a patient with metastatic prostate cancer: Response to epsilon aminocaproic acid. Cancer 70:656-658, 1992
12. Lowe FC, Somers WJ: The use of ketoconazole in the emergency management of disseminated intravascular coagulation due to metastatic prostatic cancer. J Urol 137:1000-1002, 1987
13. Pergament ML, Swaim WR, Blackard CE: Disseminated intravascular coagulation in the urologic patient. J Urol 116:1-7, 1976
14. Goldenberg SL, Fenster HN, Perler Z, et al: Disseminated intravascular coagulation in carcinoma of the prostate: Role of estrogen therapy. Urology 22:130-132, 1983
15. Sallah S, Gagnon GA: Reversion of primary hyperfibrinogenolysis in patients with hormone-refractory prostate cancer using docetaxel. Cancer Invest 18:191-196, 2000